Diversa Corporation
Records under this name other than patents Diversa Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,531,166 | IL-1BETA Binding Antibodies and Fragments Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 7,582,742 | Nucleic acids encoding IL-1beta binding antibodies Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,695,717 | Method of Treating an IL-1 Related Inflammatory Disease or Condition Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,744,865 | IL1-BETA Binding Antibodies and Fragments Thereof Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,744,866 | IL-1BETA Binding Antibodies and Binding Fragments Thereof Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,829,093 | Method of Treating an IL-1 Related Autoimmune Disease or Condition Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,829,094 | Method of Treating an IL-1 Related Cancer Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,943,121 | IL-1BETA Binding Antibodies and Fragments Thereof Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 7,988,968 | Method of Treating an IL-1 Related Coronary Condition Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |
| US 8,377,442 | A Method of Treating Inflammatory Eye Disease with IL-1BETA Binding Antibodies Formerly held Term ended Term ended Jun 21, 2026 · High confidence | Term ended | Term ended Jun 21, 2026 | High confidence |